Deckers-Kocken JM and Pasmans SG |
Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. |
2005 |
Arch. Dis. Child. |
pmid:15851442
|
Hofman T et al. |
Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. |
2006 |
Arch. Dis. Child. |
pmid:16798785
|
Nishimuta K and Ito Y |
Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice. |
2003 |
Arch. Dermatol. Res. |
pmid:12624780
|
Ito F et al. |
FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9. |
1999 |
Arch. Dermatol. Res. |
pmid:10367710
|
Lubaki LJ et al. |
Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus. |
2010 |
Arch. Dermatol. Res. |
pmid:19547993
|
Eberlein-König B et al. |
Modulation of histamine release in vitro by FK506 and interleukin-3 is determined by sequence of incubation. |
1997 |
Arch. Dermatol. Res. |
pmid:9373722
|
Hultsch T et al. |
Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin. |
1998 |
Arch. Dermatol. Res. |
pmid:9681677
|
GarcÃa-GarcÃa B et al. |
Frosch' surface microscopy score for the assessment of steroid-induced atrophy. |
2014 |
Arch. Dermatol. Res. |
pmid:24402286
|
Paus R et al. |
Hair growth control by immunosuppression. |
1996 |
Arch. Dermatol. Res. |
pmid:8818191
|
Furukawa F et al. |
FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. |
1995 |
Arch. Dermatol. Res. |
pmid:7487142
|
Ockenfels HM et al. |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. |
1995 |
Arch. Dermatol. Res. |
pmid:7541191
|
Yoon NY et al. |
Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. |
2015 |
Arch. Dermatol. Res. |
pmid:25786383
|
Hofmann M et al. |
Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. |
2013 |
Arch. Dermatol. Res. |
pmid:23242470
|
Toyota N et al. |
Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. |
1996 |
Arch. Dermatol. Res. |
pmid:8844128
|
Engelhart K et al. |
In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. |
2005 |
Arch. Dermatol. Res. |
pmid:15952007
|
Hultsch T et al. |
Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. |
1998 |
Arch. Dermatol. Res. |
pmid:9808344
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Borro JM et al. |
Long-term success of combined kidney-lung transplantation in a patient with cystic fibrosis. |
2013 |
Arch. Bronconeumol. |
pmid:23427867
|
Reig Mezquida JP et al. |
Thrombotic microangiopathy associated with tacrolimus in lung transplantation. |
2015 |
Arch. Bronconeumol. |
pmid:25138798
|
Zurbano F et al. |
Maternity and lung transplantation: cases in Spain. |
2012 |
Arch. Bronconeumol. |
pmid:22771003
|
Wen H et al. |
Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels. |
2012 |
Arch. Biochem. Biophys. |
pmid:22100703
|
Vincent SH et al. |
In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. |
1992 |
Arch. Biochem. Biophys. |
pmid:1373595
|
Yin M and Ochs RS |
Mechanism for the paradoxical inhibition and stimulation of calcineurin by the immunosuppresive drug tacrolimus (FK506). |
2003 |
Arch. Biochem. Biophys. |
pmid:14592464
|
Salowe SP and Hermes JD |
Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes. |
1998 |
Arch. Biochem. Biophys. |
pmid:9675023
|
Tomono M et al. |
Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. |
1998 |
Arch. Biochem. Biophys. |
pmid:9606972
|
Kakegawa T et al. |
Rapamycin induces binding activity to the terminal oligopyrimidine tract of ribosomal protein mRNA in rats. |
2002 |
Arch. Biochem. Biophys. |
pmid:12051685
|
Mukerjee N et al. |
Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. |
2000 |
Arch. Biochem. Biophys. |
pmid:10898953
|
Fryer JP et al. |
Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. |
1996 |
Arch Surg |
pmid:8546583
|
Harmon JV et al. |
Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion. |
2001 |
Arch Surg |
pmid:11448397
|
Echigo Y et al. |
Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. |
1995 |
Arch Surg |
pmid:7528496
|
Freise CE et al. |
Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. |
2003 |
Arch Surg |
pmid:14557130
|
Johnson MW et al. |
Hepatitis C viral infection in liver transplantation. |
1996 |
Arch Surg |
pmid:8611094
|
Stötter H and Lotze MT |
Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7. |
1991 |
Arch Surg |
pmid:1726819
|
Sánchez Ferreiro AV and Muñoz Bellido L |
[Tacrolimus in the treatment of atopic kerato-conjunctivitis]. |
2013 |
Arch Soc Esp Oftalmol |
pmid:23886369
|
RodrÃguez-AusÃn P et al. |
Topical tacrolimus 0.03% for the treatment of ocular psoriasis. |
2016 |
Arch Soc Esp Oftalmol |
pmid:27130870
|
Rybojad M |
[Atopic dermatitis]. |
2012 |
Arch Pediatr |
pmid:22796288
|
Monchaud C et al. |
[Long lasting side effects of immunosuppressants in children]. |
2007 |
Arch Pediatr |
pmid:17442546
|
Geramizadeh B et al. |
Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran. |
2010 |
Arch Iran Med |
pmid:20804309
|
Dehghani SM et al. |
Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients. |
2010 |
Arch Iran Med |
pmid:20187665
|
Yeh C et al. |
Effect of FK506 on functional recovery after facial nerve injury in the rat. |
2007 Sep-Oct |
Arch Facial Plast Surg |
pmid:17875826
|
Kreuter A et al. |
1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. |
2006 |
Arch Dermatol |
pmid:16983001
|
Stern RS |
Topical calcineurin inhibitors labeling: putting the "box" in perspective. |
2006 |
Arch Dermatol |
pmid:16983018
|
Bakos L and Bakos RM |
Focal acne during topical tacrolimus therapy for vitiligo. |
2007 |
Arch Dermatol |
pmid:17875902
|
Ruzicka T et al. |
Tacrolimus: the drug for the turn of the millennium? |
1999 |
Arch Dermatol |
pmid:10328199
|
Laffitte E et al. |
Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. |
2003 |
Arch Dermatol |
pmid:12810500
|
Chu J et al. |
Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. |
2003 |
Arch Dermatol |
pmid:12810523
|
Qureshi AA and Fischer MA |
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. |
2006 |
Arch Dermatol |
pmid:16702502
|
Thiers BH |
Topical tacrolimus: treatment failure in a patient with alopecia areata. |
2000 |
Arch Dermatol |
pmid:10632221
|
Rotunda AM et al. |
Hyperkeratotic plaques on the palms and soles. Palmoplantar lichen planus, hyperkeratotic variant. |
2004 |
Arch Dermatol |
pmid:15492196
|
Laffitte E and Panizzon RG |
Is topical tacrolimus really an effective therapy for Hailey-Hailey disease? |
2004 |
Arch Dermatol |
pmid:15492199
|
|
Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group. |
1996 |
Arch Dermatol |
pmid:8629845
|
Firooz A et al. |
Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. |
2006 |
Arch Dermatol |
pmid:16924062
|
Jegasothy BV et al. |
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. |
1992 |
Arch Dermatol |
pmid:1376102
|
Van Leent EJ et al. |
Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. |
1998 |
Arch Dermatol |
pmid:9681343
|
Choi CJ and Nghiem P |
Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. |
2001 |
Arch Dermatol |
pmid:11559218
|
Mandelin J et al. |
Effect of oral acetylsalicylic acid on burning caused by tacrolimus ointment in patients with atopic dermatitis. |
2010 |
Arch Dermatol |
pmid:20956662
|
Lener EV et al. |
Successful treatment of erosive lichen planus with topical tacrolimus. |
2001 |
Arch Dermatol |
pmid:11295919
|
Mehrabi D and Pandya AG |
A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. |
2006 |
Arch Dermatol |
pmid:16847214
|
Colebunders R et al. |
HIV eosinophilic folliculitis in Uganda. |
2006 |
Arch Dermatol |
pmid:16847219
|
Lebwohl M et al. |
Proven efficacy of tacrolimus for facial and intertriginous psoriasis. |
2005 |
Arch Dermatol |
pmid:16172314
|
Neill SM and Lewis FM |
Vulvovaginal lichen planus: a disease in need of a unified approach. |
2008 |
Arch Dermatol |
pmid:19015426
|
Gorman CR and White SW |
Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. |
2005 |
Arch Dermatol |
pmid:16172323
|
Cooper SM et al. |
Vulvovaginal lichen planus treatment: a survey of current practices. |
2008 |
Arch Dermatol |
pmid:19015433
|
Heffernan MP et al. |
0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus. |
2005 |
Arch Dermatol |
pmid:16172325
|
Lally A et al. |
Penile pyoderma gangrenosum treated with topical tacrolimus. |
2005 |
Arch Dermatol |
pmid:16172330
|
Passeron T et al. |
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. |
2004 |
Arch Dermatol |
pmid:15381545
|
Bunker CB et al. |
Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. |
2004 |
Arch Dermatol |
pmid:15381566
|
Le Cleach L et al. |
Is topical monotherapy effective for localized pyoderma gangrenosum? |
2011 |
Arch Dermatol |
pmid:21242400
|
Ehst BD and Warshaw EM |
Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. |
2004 |
Arch Dermatol |
pmid:15313828
|
Eiling E et al. |
Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption. |
2008 |
Arch Dermatol |
pmid:18794482
|
Byrd JA et al. |
Response of oral lichen planus to topical tacrolimus in 37 patients. |
2004 |
Arch Dermatol |
pmid:15611431
|
Santos-Juanes J et al. |
Topical tacrolimus: an effective therapy for Zoon balanitis. |
2004 |
Arch Dermatol |
pmid:15611442
|
Milingou M et al. |
Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. |
2004 |
Arch Dermatol |
pmid:15611445
|
Guenova E et al. |
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. |
2011 |
Arch Dermatol |
pmid:21680759
|
Singh MN et al. |
Solitary cutaneous nodule in an immunocompromised patient. |
2007 |
Arch Dermatol |
pmid:18087016
|
Ng W and Ikeda S |
Mount Tsukuba and the origin of tacrolimus. |
2009 |
Arch Dermatol |
pmid:19289758
|
Sardana K et al. |
Effect of tacrolimus on vitiligo in absence of UV radiation exposure. |
2007 |
Arch Dermatol |
pmid:17224558
|
Carroll CL et al. |
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. |
2005 |
Arch Dermatol |
pmid:15655140
|
Yan AC et al. |
The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. |
2010 |
Arch Dermatol |
pmid:20083693
|
Ciurea AM et al. |
Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone. |
2010 |
Arch Dermatol |
pmid:20083712
|
Ward KM et al. |
Eyelash trichomegaly associated with systemic tacrolimus. |
2006 |
Arch Dermatol |
pmid:16490862
|
Ostovari N et al. |
Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. |
2006 |
Arch Dermatol |
pmid:16490866
|
Mikhail M et al. |
Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. |
2008 |
Arch Dermatol |
pmid:18427063
|
Chapman MS et al. |
0.1% tacrolimus ointment for the treatment of intertrigo. |
2005 |
Arch Dermatol |
pmid:15967933
|
Olivier V et al. |
Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. |
2002 |
Arch Dermatol |
pmid:12374539
|
Böhm M et al. |
Successful treatment of anogenital lichen sclerosus with topical tacrolimus. |
2003 |
Arch Dermatol |
pmid:12873890
|
Reitamo S et al. |
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. |
2000 |
Arch Dermatol |
pmid:10926735
|
Sugiura H et al. |
Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. |
2000 |
Arch Dermatol |
pmid:10926750
|
Byrd JA et al. |
Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. |
2004 |
Arch Dermatol |
pmid:15210463
|
Shah KN and Yan AC |
Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with netherton syndrome. |
2006 |
Arch Dermatol |
pmid:17043199
|
Antille C et al. |
Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. |
2004 |
Arch Dermatol |
pmid:15096374
|
Banky JP et al. |
Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. |
2004 |
Arch Dermatol |
pmid:15262686
|
Passeron T et al. |
Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. |
2007 |
Arch Dermatol |
pmid:17438179
|
Bruce A and Rogers RS |
New and old therapeutics for oral ulcerations. |
2007 |
Arch Dermatol |
pmid:17438186
|
Qureshi A and Fischer MA |
Topical calcineurin inhibitors revisited. |
2007 |
Arch Dermatol |
pmid:17438195
|
Carroll PB et al. |
Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. |
1994 |
Arch Dermatol |
pmid:7526802
|
Cheng A and Mann C |
Oral erosive lichen planus treated with efalizumab. |
2006 |
Arch Dermatol |
pmid:16785369
|
Sniezek PJ et al. |
Annular atrophic plaques on the arms of a 57-year-old woman. |
2006 |
Arch Dermatol |
pmid:16785386
|
Allen DM and Esterly NB |
Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. |
2002 |
Arch Dermatol |
pmid:12225004
|
Hall VC et al. |
Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. |
2003 |
Arch Dermatol |
pmid:12925404
|